1. Home
  2. GREE vs CING Comparison

GREE vs CING Comparison

Compare GREE & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Greenidge Generation Holdings Inc.

GREE

Greenidge Generation Holdings Inc.

HOLD

Current Price

$1.64

Market Cap

24.3M

Sector

Finance

ML Signal

HOLD

CING

Cingulate Inc.

HOLD

Current Price

$4.68

Market Cap

26.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GREE
CING
Founded
1937
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.3M
26.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
GREE
CING
Price
$1.64
$4.68
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$31.33
AVG Volume (30 Days)
254.7K
140.5K
Earning Date
03-31-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$62,115,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.58
$3.20
52 Week High
$2.42
$6.01

Technical Indicators

Market Signals
Indicator
GREE
CING
Relative Strength Index (RSI) 51.33 66.49
Support Level $1.45 $3.85
Resistance Level $1.75 $4.30
Average True Range (ATR) 0.12 0.28
MACD 0.00 0.06
Stochastic Oscillator 55.88 73.08

Price Performance

Historical Comparison
GREE
CING

About GREE Greenidge Generation Holdings Inc.

Greenidge Generation Holdings Inc owns and operates a vertically integrated cryptocurrency data center. Company operates in three segments: Crypto Mining, Datacenter Hosting, Power and Capacity. The company owns and operates facilities at two locations: the Torrey, New York, and Spartanburg, South Carolina. The cryptocurrency data center operations generate revenue in the form of bitcoin by earning bitcoin as rewards and transaction fees for supporting the bitcoin network with application-specific integrated circuit computers (ASICs or miners) owned or leased by the company.

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.

Share on Social Networks: